Literature DB >> 17762521

Fluoxetine and the dentate gyrus: memory, recovery of function, and electrophysiology.

Julian R Keith1, Ying Wu, Jonathon R Epp, Robert J Sutherland.   

Abstract

Chronic fluoxetine increases neurogenesis in the dentate gyrus (DG). In view of the widespread clinical use of fluoxetine and the well-established role of the DG in memory, surprisingly few studies have examined the effects of fluoxetine on memory and hippocampal electrophysiology. Additionally, few studies have evaluated the potential for fluoxetine to promote recovery of function after DG damage. Therefore, we studied the effects of long-term administration of fluoxetine on both spatial-reference memory and working memory, recovery of function after intrahippocampal colchicine infusions, which can destroy 50-70% of DG granule cells, and electrophysiological responses in the DG to perforant path stimulation in freely moving rats. Chronic fluoxetine did not affect matching-to-place or reference-memory performance in intact rats in the Morris water-maze task. Surprisingly, in rats with DG damage, recovery of function on both tasks was adversely affected by chronic fluoxetine. Finally, unlike an earlier study that reported fluoxetine-induced increases in hippocampal population spike amplitudes and excitatory postsynaptic potential slopes in urethane-anesthetized rats, electrophysiological measures in DG of freely moving rats were not affected by chronic fluoxetine treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762521      PMCID: PMC2668873          DOI: 10.1097/FBP.0b013e3282d28f83

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  40 in total

1.  Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus.

Authors:  R Manev; T Uz; H Manev
Journal:  Eur J Pharmacol       Date:  2001-05-25       Impact factor: 4.432

2.  Adrenalectomy-induced granule cell degeneration in the hippocampus causes spatial memory deficits that are not reversed by chronic treatment with corticosterone or fluoxetine.

Authors:  Simon C Spanswick; Jonathan R Epp; Julian R Keith; Robert J Sutherland
Journal:  Hippocampus       Date:  2007       Impact factor: 3.899

Review 3.  Retrograde amnesia after hippocampal damage: recent vs. remote memories in two tasks.

Authors:  R J Sutherland; M P Weisend; D Mumby; R S Astur; F M Hanlon; A Koerner; M J Thomas; Y Wu; S N Moses; C Cole; D A Hamilton; J M Hoesing
Journal:  Hippocampus       Date:  2001       Impact factor: 3.899

Review 4.  Stress, metaplasticity, and antidepressants.

Authors:  René Garcia
Journal:  Curr Mol Med       Date:  2002-11       Impact factor: 2.222

5.  Involvement of microtubule integrity in memory impairment caused by colchicine.

Authors:  Takahiro Nakayama; Tohru Sawada
Journal:  Pharmacol Biochem Behav       Date:  2002 Jan-Feb       Impact factor: 3.533

6.  The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels.

Authors:  Koji Hara; R Adron Harris
Journal:  Anesth Analg       Date:  2002-02       Impact factor: 5.108

7.  Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity.

Authors:  C A Stewart; I C Reid
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

8.  Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

Authors:  J E Malberg; A J Eisch; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

9.  Environmental influences on functional outcome after a cortical infarct in the rat.

Authors:  Anette Risedal; Bengt Mattsson; Per Dahlqvist; Claes Nordborg; Tommy Olsson; Barbro B Johansson
Journal:  Brain Res Bull       Date:  2002-07       Impact factor: 4.077

10.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

View more
  8 in total

Review 1.  Roles for oestrogen receptor β in adult brain function.

Authors:  R J Handa; S Ogawa; J M Wang; A E Herbison
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

2.  Ketamine Affects the Neurogenesis of the Hippocampal Dentate Gyrus in 7-Day-Old Rats.

Authors:  He Huang; Cun-Ming Liu; Jie Sun; Ting Hao; Chun-Mei Xu; Dan Wang; Yu-Qing Wu
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

3.  Factors influencing cerebral plasticity in the normal and injured brain.

Authors:  Bryan Kolb; G Campbell Teskey; Robbin Gibb
Journal:  Front Hum Neurosci       Date:  2010-11-02       Impact factor: 3.169

4.  Sevoflurane exposure in 7-day-old rats affects neurogenesis, neurodegeneration and neurocognitive function.

Authors:  Fang Fang; Zhanggang Xue; Jing Cang
Journal:  Neurosci Bull       Date:  2012-09-11       Impact factor: 5.203

5.  Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48.

Authors:  Elias Pavlopoulos; Sidonie Jones; Stylianos Kosmidis; Maggie Close; Carla Kim; Olga Kovalerchik; Scott A Small; Eric R Kandel
Journal:  Sci Transl Med       Date:  2013-08-28       Impact factor: 17.956

6.  Chronic fluoxetine treatment suppresses plasticity (long-term potentiation) in the mature rodent primary auditory cortex in vivo.

Authors:  Hans C Dringenberg; Leora R Branfield Day; Deanna H Choi
Journal:  Neural Plast       Date:  2014-02-25       Impact factor: 3.599

7.  Neurogenesis-mediated forgetting minimizes proactive interference.

Authors:  Jonathan R Epp; Rudy Silva Mera; Stefan Köhler; Sheena A Josselyn; Paul W Frankland
Journal:  Nat Commun       Date:  2016-02-26       Impact factor: 14.919

8.  Ketamine affects the integration of developmentally generated granule neurons in the adult stage.

Authors:  Zhanqiang Zhao; Bing Li; Yuqing Wu; Xujun Chen; Yan Guo; Yang Shen; He Huang
Journal:  BMC Neurosci       Date:  2019-12-18       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.